Strategic Patent and Commercialization Journey of Nemonoxacin: From Molecule to Market

— —

Chi-Hsin Richard King

Strategic Patent and Commercialization Journey of Nemonoxacin

Name: Strategic Patent and Commercialization Journey of Nemonoxacin
Price: 39.95 AUD
Availability: OutOfStock
ISBN: 9781971588223

From Molecule to Market

Chi-Hsin Richard King

$39.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We will update you on expected arrival time to us. If this delay is too long, please let us know within 2 business days and we can give you options regarding cancelling or adjusting your order. More details on cancelling your order can be found in our Terms of Trade.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Chi-Hsin Richard King
25 March 2026

Manufacturing industries; Pre-clinical medicine: basic sciences; Impact of science & technology on society; Biotechnology

Summary
Details

This second volume of Strategic Patent and Commercialization Journey of Nemonoxacin examines the molecule's progression through the most consequential stages of its development. Moving from late-phase clinical evaluation to regulatory negotiation, manufacturing scale-up, and early post-approval deployment, the narrative situates Nemonoxacin within the broader scientific and policy environment shaping antimicrobial innovation.

Central to this account is TaiGen's systematic construction of a durable intellectual property and life-cycle management strategy. Through data-driven patent generation, jurisdiction-specific protection plans, and targeted extensions of clinical and formulation claims, the company sought to secure long-term market viability in a competitive therapeutic domain.

Set against shifting regional politics and Taiwan's growing biotech ambitions, this volume offers a close, unvarnished look at how a medicine survives the long arc from development to market - and how a company uses every lever available, from clinical evidence to life-cycle management, to keep that arc intact.

For readers interested in the human and strategic story behind drug development, it is both a case study and a record of a pivotal moment in Taiwan's scientific history.

By: Chi-Hsin Richard King
Imprint: Chi-Hsin Richard King
Dimensions: Height: 229mm, Width: 152mm, Spine: 7mm
Weight: 186g
ISBN: 9781971588223
ISBN 10: 1971588229
Pages: 132
Publication Date: 25 March 2026
Audience: General/trade , ELT Advanced
Format: Paperback
Publisher's Status: Active